Tritonix.ai

News / Taiwan / economic_daily

FTSE Russell Quarterly Review: PharmaEssentia Joins Taiwan 50 Index, Alchip Removed

Health Technology · Biotechnology · economic_daily · 2026-09-04

0050

The Taiwan Index Plus Corporation has announced its quarterly index adjustments, with PharmaEssentia entering the Taiwan 50 index while Alchip is removed, effective September 21.

What Happened

Index Rebalancing Announcement: The Taiwan Index Plus Corporation has released the results of its quarterly review for the FTSE Russell index series, including the Taiwan 50, Mid-Cap 100, and Information Technology indices. These adjustments are designed to reflect current market capitalizations and will take effect at the start of trading on September 21.

Taiwan 50 Component Changes: ETFs tracking the Taiwan 50 index, such as Yuanta Taiwan 50 and Fubon Taiwan 50, will see PharmaEssentia added to their holdings, while Alchip-KY will be removed. This move aligns with market expectations regarding shifts in market capitalization and highlights the growing importance of the biotechnology sector in major indices.

Mid-Cap and Tech Index Shifts: The Taiwan Mid-Cap 100 index will see four additions, including Alchip-KY, Elite Semiconductor Memory Technology, Lianyou Metal, and Peel Biotech, while Taiwan Elite, Nuvoton, PharmaEssentia, and Tatung will be removed. Additionally, the Fubon Taiwan Technology index will add Elite Semiconductor Memory Technology and remove Nuvoton.

Effective Date and Contingency: The changes are scheduled to become effective after the close of trading on September 18. Should any existing component be removed before the next scheduled review, the vacancy will be filled by candidates from the reserve list, which is effective immediately.

Read original

More in Health Technology

Huaan Plans $300 Million Capital Raise to Accelerate Drug Trials and Licensing

Health Technology · cnyes · 2026-09-04

Taiwan-based Huaan (6657) is set to raise NT$300 million through a new share issuance to fund clinical trials for its F705PD and F703EB drug candidates.

6657

FTSE Russell Announces Taiwan Index Rebalancing: PharmaEssentia In, Alchip Out

Health Technology · economic_daily · 2026-09-04

FTSE Russell has unveiled its latest quarterly index review for Taiwan, with PharmaEssentia joining the Taiwan 50 Index while Alchip-KY is removed.

1301, 2371, 2379, 2441, 2615, 2637, 2845, 2855, 3006, 3189, 3406, 3450, 3481, 3661, 4583, 4919, 6005, 6446, 6944, 6949, 7610, 8039, 8454

Skylabs Soars 135% on KOSDAQ Debut

Health Technology · yonhap_finance · 2026-09-04

Medical device manufacturer Skylabs closed its first day of trading on the KOSDAQ up 135% from its IPO price, marking a successful market entry.

386380

Latest in Taiwan

Huaan Plans $300 Million Capital Raise to Accelerate Drug Trials and Licensing

Health Technology · cnyes · 2026-09-04

Taiwan-based Huaan (6657) is set to raise NT$300 million through a new share issuance to fund clinical trials for its F705PD and F703EB drug candidates.

6657

Taichung Power Plant Hits Milestone: Gas Units at Full Capacity, Coal Units to be Dismantled

Utilities · cnyes · 2026-09-04

Taichung Power Plant has achieved full capacity with its new gas-fired units and plans to begin dismantling coal-fired units in October to meet 2034 goals.

PwC Taiwan and TPEx Collaborate to Bridge SMEs to Capital Markets

Finance · economic_daily · 2026-09-04

PwC Taiwan and the Taipei Exchange hosted an innovation matchmaking event to connect SMEs with venture capital, fostering growth and capital market readiness.

Lite-On Semiconductor Advances Silicon Photonics with 1.6T Module Milestone

Electronic Technology · cnyes · 2026-09-04

Lite-On Semiconductor showcases its 1.6T high-speed optical transceiver module, targeting the 3.2T market through international collaboration in silicon photonics.

8111